APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

Huff, AL, Wongthida, P, Kottke, T et al. (12 more authors) (2018) APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Molecular Therapy - Oncolytics, 11. pp. 1-13.

Abstract

Metadata

Authors/Creators:
  • Huff, AL
  • Wongthida, P
  • Kottke, T
  • Thompson, JM
  • Driscoll, CB
  • Schuelke, M
  • Shim, KG
  • Harris, RS
  • Molan, A
  • Pulido, JS
  • Selby, PJ
  • Harrington, KJ
  • Melcher, A
  • Evgin, L
  • Vile, RG
Copyright, Publisher and Additional Information: © 2018 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: APOBEC3; VSV; oncolytic virus; viral resistance; therapeutic resistance
Dates:
  • Published: 21 December 2018
  • Accepted: 23 August 2018
  • Published (online): 29 August 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Biomarkers and Therapy (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 13 Dec 2018 09:52
Last Modified: 13 Dec 2018 10:00
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.omto.2018.08.003

Share / Export

Statistics